Shanghai Pharmaceuticals Holding Co (SHSE:601607) Cyclically Adjusted PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:601607 Shanghai Pharmaceuticals Holding Co Ltd SHSE:601607
73 GF Score
Price ¥16.04
GF Value ¥19.82
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Shanghai Pharmaceuticals Holding Co  (SHSE:601607) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PS Ratio Related Terms


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PS Ratio Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.38 0.32 0.28 0.33 0.27

Shanghai Pharmaceuticals Holding Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.28 0.27 0.25 0.23

SHSE:601607 vs MCK, COR, CAH: Cyclically Adjusted PS Ratio Comparison

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio falls into.


SHSE:601607
73GF Score
Shanghai Pharmaceuticals Holding Co Ltd SHSE:601607
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Shanghai Pharmaceuticals Holding Co's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=19.472/116.0564*116.0564
=19.472

Current CPI (Jun. 2026) = 116.0564.

Shanghai Pharmaceuticals Holding Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 9.318 99.900 10.825
201506 9.580 99.500 11.174
201509 10.418 100.500 12.031
201603 10.888 102.200 12.364
201609 11.462 102.400 12.991
201703 12.321 103.200 13.856
201709 12.367 104.100 13.787
201803 13.038 105.300 14.370
201806 13.896 104.900 15.374
201809 14.680 106.600 15.982
201812 14.596 106.500 15.906
201903 16.188 107.700 17.444
201906 16.385 107.700 17.656
201909 16.904 109.800 17.867
202003 14.232 112.300 14.708
202006 16.437 110.400 17.279
202009 18.704 111.700 19.433
202012 18.151 111.500 18.893
202103 18.098 112.662 18.643
202106 18.873 111.769 19.597
202109 19.611 112.215 20.282
202112 19.300 113.108 19.803
202203 20.012 114.335 20.313
202206 14.828 114.558 15.022
202209 17.018 115.339 17.124
202212 15.516 115.116 15.643
202303 17.906 115.116 18.052
202306 17.921 114.558 18.155
202309 17.529 115.339 17.638
202312 16.903 114.781 17.091
202403 18.943 115.227 19.079
202406 18.650 114.781 18.857
202409 18.954 115.785 18.998
202412 17.698 114.893 17.877
202503 19.082 115.116 19.238
202506 19.100 114.907 19.291
202509 19.815 115.471 19.915
202512 18.474 115.832 18.510
202603 20.295 116.303 20.252
202606 19.472 116.056 19.472

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Shanghai Pharmaceuticals Holding Co (SHSE:601607) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued. The current stock price of ¥16.04 is trading 19.1% below its estimated GF Value™ of ¥19.82. GuruFocus considers Shanghai Pharmaceuticals Holding Co to be Modestly Undervalued.

Key valuation signals for SHSE:601607:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: ¥19.82 vs. price of ¥16.04 (19.1% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the SHSE:601607 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Pharmaceuticals Holding Co Business Description

Other Exchanges 02607:Hong KongS1R:Germany
Address No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
73GF Score

Get the complete analysis for SHSE:601607

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥16.04
Price
¥19.82
GF Value